Oregon Health & Science University

2017 Program schedule

Friday, September 8

7:30 a.m. Registration and breakfast

8:30 a.m. Welcome

Heart Failure

8:40 a.m. Chronic heart failure: integrating new therapies into clinical practice
Clyde Yancy, M.D.

9:20 a.m. Acute heart failure: management, pearls, and lessons learned
Mariell Jessup, M.D., F.A.H.A., F.A.C.C., F.E.S.C.

10 a.m. Break


10:20 a.m. PCSK9 inhibition: promise fulfilled?
Christie Ballantyne, M.D.

11 a.m. Providing evidence for subclinical atherosclerosis in risk assessment
Michael Blaha, M.D., M.P.H.

11:40 a.m. Lunch


1 p.m. Coronary microvascular dysfunction in ischemic heart disease: implications for diagnosis and management
Marcelo DiCarli, M.D.

1:40 p.m. Multimodality imaging in structural heart disease
Partho Sengupta, M.D.

2:20 p.m. Break

Structural heart disease

2:40 p.m. Mitral valve therapy: the role of surgery in the era of percutaneous therapy
Patrick McCarthy, M.D.

3:20 p.m. Aortic valve: TAVR: Standard care of the future or a promise unfulfilled?
Samir Kapadia, M.D.

4 p.m. Break

4:20 p.m. Keynote address
Albert Starr, M.D.

5 p.m. Wine and hors d'oeuvres reception

Saturday, September 9

7:30 a.m. Breakfast

8:30 a.m. Welcome

Peripheral vascular disease

8:40 a.m. Peripheral vascular disease; it's a matter of life and limb
Mark Creager, M.D.

9:20 a.m. Spectrum of PAD therapies – who, when and how?
Brian DeRubertis, M.D.

10 a.m. Break


10:20 a.m. Left atrial appendage closure — state of the art
Dhanunjaya Lakkireddy, M.D., F.A.C.C., F.H.R.S.

11 a.m. Prevention of sudden cardiac death
Jeanie Poole, M.D.

11:40 a.m. Wrap-up and conclusion

Noon Adjourn